Extending Use of Biomarkers to Pediatric Population with TBI

Researchers and clinicians hope to make using biomarkers to diagnose TBI in infants or even in pre-natal cord blood a reality.

See more videos with Dr. Ronald Hayes.

Posted on BrainLine April 2, 2013.

Produced by Brian King, Vicky Youcha, and Erica Queen, BrainLine.

About the author: Ronald Hayes, PhD

Ronald Hayes, PhD is a co-founder and president of Banyan Biomarkers, Inc. He is director of Banyan’s Clinical Programs and Banyan Laboratories.